PALB2 and breast cancer: Mutational signature 3, which is related to defective HRR (Nik-Zainal et al., 2016), was present in 4 of PALB2-associated breast tumors, including all three PALB2-NULL BC cases, but absent among sporadic breast tumors (Supplementary Figure S1–S2).